Summary
- Apollo Hospitals and The ePlane Company signed an MoU to bring electric air ambulances and medical delivery drones into India’s emergency care system.
- ePlane’s e200X aircraft aims to move patients seven times faster than road transport, but it’s still awaiting DGCA certification.
- The deal could also lead to Apollo making a strategic investment in ePlane, though terms are yet to be finalized.
Every 3.5 minutes, someone dies in a road accident in India. Most of them never reach a trauma centre within the golden hour, the first 60 minutes that decide survival odds. Apollo Hospitals just placed a bet on fixing that gap from the sky. It has signed an MoU with Chennai based aerospace startup The ePlane Company to bring electric air ambulances and medical delivery drones into India’s emergency healthcare network.
What Happened (Apollo Hospitals and The ePlane Company signed an MoU)
The MoU was signed in Chennai and announced at the Farnborough International Airshow in the UK on July 23. It brings together Apollo’s hospital network and ePlane’s aircraft, which are still working through regulatory approval in India.
Under the agreement, Apollo will evaluate ePlane’s e200X electric vertical take off and landing aircraft for inter-hospital transfers, trauma response, cardiac and stroke emergencies, and organ transportation. ePlane’s subsidiary, Amber Wings, will handle the drone side of the partnership, moving blood products, organs, vaccines, medicines and diagnostic samples between facilities.
Apollo is bringing real scale to the table. The hospital group will contribute its network of 1,066 ambulances, hospitals, clinics, pharmacies and diagnostic centres to build what both companies describe as a connected emergency response system that combines air and road transport.
Read More : World-First Fan-in-Wing Transition Flight: How Horizon Cavorite X7 Redefines eVTOL in 2025
Why ePlane, Why Now
ePlane isn’t new to this conversation. The startup has already picked up an order from ICATT for 788 air ambulances, and it’s targeting DGCA type certification for the e200X in early 2027. That timeline matters, because the aircraft at the centre of this MoU doesn’t exist commercially yet. What’s being signed today is a plan, not a deployed fleet.
The pitch is speed and cost. ePlane says the e200X can move patients roughly seven times faster than a road ambulance, at a fraction of what a traditional helicopter transfer costs. For a country where urban traffic and long distances routinely eat into the golden hour, that math is the whole argument.
There’s also a financial thread worth watching. The MoU leaves open the possibility of a future strategic investment by Apollo in ePlane, subject to terms still being worked out. If that happens, it turns a healthcare partnership into a capital bet on India’s eVTOL sector.
Read More: Ashneer Grover Launches Fund My Staff: What It Is, How It Works, Who It’s For
Startup INDIAX Take
This deal says more about Apollo’s ambitions than about ePlane’s readiness. Apollo isn’t buying finished aircraft, it’s securing first mover position in a category that barely exists in India yet. For ePlane, an anchor partner with 1,066 touchpoints across the country is worth more right now than any single aircraft order, because it gives regulators and future customers a reason to take the e200X seriously before it’s even certified. Founders building in deep tech and healthtech should read this as a signal that large incumbents are willing to move early on unproven hardware, provided the problem is big enough and the upside is clear enough.
Why This Matters
Road accidents kill more than 170,000 people in India every year, and only one in five patients reach trauma care within the golden hour. That’s not a small gap, it’s the difference between survivable and fatal outcomes for a huge share of emergencies. Air ambulances have existed in India before, but mostly as an expensive, helicopter based option available to very few. An electric alternative that costs less to run changes who can realistically access it, which is the more interesting story here than the aircraft itself.
The Bigger Picture
India’s eVTOL sector is still pre-commercial, but it’s no longer theoretical. Certification timelines like ePlane’s 2027 target, combined with large incumbents like Apollo signing on early, suggest the regulatory and business groundwork is happening in parallel rather than one waiting on the other. Whether this scales depends on DGCA approval actually landing on schedule and on Apollo following through with orders once the aircraft clears certification. Until then, this is a partnership on paper with a real network behind it.
If you’re tracking India’s healthtech and deep tech crossover, this is one to watch closely over the next year. Drop your take in the comments, and check out more Startup INDIAX coverage on India’s aviation and healthcare startups below.
FAQ
Is the Apollo-ePlane air ambulance service operational yet?
No. The e200X aircraft is still undergoing DGCA type certification, targeted for early 2027, so this partnership is currently at the planning and evaluation stage.
What is The ePlane Company?
The ePlane Company, legally registered as Ubifly Technologies Private Limited, is a Chennai based aerospace startup building the e200X electric aircraft, with a drone subsidiary called Amber Wings.
What will the air ambulances be used for?
Apollo plans to evaluate the e200X for inter-hospital patient transfers, trauma response, cardiac and stroke emergencies, and organ transportation.
Will Apollo invest in ePlane?
The MoU leaves open the possibility of a future strategic investment by Apollo in ePlane, but the terms haven’t been finalized yet.
How much faster are these air ambulances compared to road transport?
ePlane says the e200X is designed to move patients up to seven times faster than road transport, at a lower cost than a traditional helicopter transfer.
